Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Dorbaxin Forte Tablets

Dorbaxin Forte Tablets

NAFDAC Reg. No. A4-5488 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 29 October 2026 · synced automatically from official sources.
Producto
Dorbaxin Forte Tablets
Número NAFDAC
A4-5488
Principio activo
Methocarbamol; Paracetamol
Dosis
400 mg; 500 mg
Forma
Tablet
Tamaño del envase
10 x 1 x 10's (in Alu-PVC blisters)
Fabricante
No Constan
Solicitante (titular)
Xcel Pharmaceutical Limited
Approved
22 Oct 2022
Estado
Activo Ver en NAFDAC ↗
Registro válido hasta
21 Oct 2027
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Methocarbamol: uses, dosage and brands worldwide

Lo que encontramos

  • Dorbaxin Forte Tablets is on the NAFDAC register with an active registration (A4-5488). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Dorbaxin Forte Tablets

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Cómo tomarlo y con qué frecuencia
  • Methocarbamol tablets, USP, 500 mg – Adults: Initial dosage: 3 tablets q.i.d
  • Maintenance dosage: 2 tablets q.i.d
  • Methocarbamol tablets, USP: 750 mg – Adults: Initial dosage: 2 tablets q.i.d
  • Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d
  • Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered)
  • Thereafter, the dosage can usually be reduced to approximately 4 grams a day
Infancia
  • Safety and effectiveness of Methocarbamol tablets, USP
  • In pediatric patients below the age of 16 have not been established
While you are taking it
  • Patients should be cautioned that methocarbamol may cause drowsiness or dizziness, which may impair their ability to operate motor vehicles or machinery
  • Because methocarbamol may possess a general CNS-depressant effect, patients should be cautioned about combined effects with alcohol and other CNS depressants
Talk to a doctor first if

Methocarbamol tablets, USP are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.

Medicines it may not mix with

See Warnings and Precautions for interaction with CNS drugs and alcohol. Methocarbamol may inhibit the effect of pyridostigmine bromide. Therefore, methocarbamol should be used with caution in patients with myasthenia gravis receiving anticholinesterase agents.

Warnings

Since methocarbamol may possess a general CNS depressant effect, patients receiving Methocarbamol tablets, USP should be cautioned about combined effects with alcohol and other CNS depressants. Safe use of Methocarbamol tablets, USP has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, Methocarbamol tablets, USP should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards (see Precautions, Pregnancy ). …

Posibles efectos secundarios

Adverse reactions reported coincident with the administration of methocarbamol include: Body as a whole: Anaphylactic reaction, angioneurotic edema, fever, headache Cardiovascular system: Bradycardia, flushing, hypotension, syncope, thrombophlebitis Digestive system: Dyspepsia, jaundice (including cholestatic jaundice), nausea and vomiting Hemic and lymphatic system: Leukopenia Immune system: Hypersensitivity reactions Nervous system: Amnesia, confusion, diplopia, dizziness or lightheadedness, drowsiness, insomnia, mild muscular incoordination, nystagmus, sedation, seizures (including grand mal), vertigo Skin and special senses: Blurred vision, conjunctivitis, nasal congestion, metallic tast …

Pregnancy and breastfeeding

Pregnancy Teratogenic effects Pregnancy Category C Animal reproduction studies have not been conducted with methocarbamol. It is also not known whether methocarbamol can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Methocarbamol tablets, USP should be given to a pregnant woman only if clearly needed. …

If you take too much

Limited information is available on the acute toxicity of methocarbamol. Overdose of methocarbamol is frequently in conjunction with alcohol or other CNS depressants and includes the following symptoms: nausea, drowsiness, blurred vision, hypotension, seizures, and coma. In post-marketing experience, deaths have been reported with an overdose of methocarbamol alone or in the presence of other CNS depressants, alcohol or psychotropic drugs. Treatment Management of overdose includes symptomatic and supportive treatment. …

How to store it

Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F). [see USP Controlled Room Temperature]. Dispense in tight container.

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2020-08-01.

Label for methocarbamol and paracetamol, the active ingredient registered with NAFDAC.

Check your pack of Dorbaxin Forte Tablets

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Dorbaxin Forte Tablets

What is in Dorbaxin Forte Tablets?

Dorbaxin Forte Tablets contains Methocarbamol; Paracetamol (400 mg; 500 mg), as tablet, according to its NAFDAC registration record.

Is Dorbaxin Forte Tablets registered with NAFDAC?

Yes. Dorbaxin Forte Tablets is listed on the NAFDAC register under registration number A4-5488, and its registration is active as of 29 October 2026.

Has Dorbaxin Forte Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Dorbaxin Forte Tablets in our automatically synced alert list.

How can I check that my pack of Dorbaxin Forte Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-5488, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Dorbaxin Forte Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Methocarbamol tablets, USP, 500 mg – Adults: Initial dosage: 3 tablets q.i.d. Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg – Adults: Initial dosage: 2 tablets q.i.d. Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d. Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered)…

What is Dorbaxin Forte Tablets used for?

Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man. (Summarised from the official U.S. FDA label for methocarbamol and paracetamol. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Dorbaxin Forte Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.